Aspirin trialled as part of potential treatment for type of aggressive breast cancer
The cheap and widely-available drug is being tested to see if it can make tumours more sensitive to immunotherapy for patients with triple negative breast cancer.
The trial, funded by the Breast Cancer Now Catalyst Programme, will test the drug avelumab both with and without aspirin before patients have surgery and chemotherapy.
Successful results could lead to further clinical trials of aspirin and avelumab for incurable secondary triple negative breast cancer, which affects around 8,000 women in the UK each year.
The less common but often more aggressive type of breast cancer disproportionately affects young women and black women.
Dr Anne Armstrong, a consultant medical oncologist from the Christie NHS Foundation Trust in Manchester, will lead the study.
She said: "Our earlier research has suggested that aspirin can make certain types of immunotherapy more effective by preventing the cancer from making substances that weaken the immune response.
"Anti-inflammatory drugs like aspirin could hold the key to increasing the effectiveness of immunotherapy when used at the same time.
"Trialling the use of a drug like aspirin is exciting because it is so widely available and inexpensive to produce.
"We hope our trial will show that, when combined with immunotherapy, aspirin can enhance its effects and may ultimately provide a safe new way to treat breast cancer."
Dr Simon Vincent, director of research, support and influencing at Breast Cancer Now, said: "The 8,000 women diagnosed with triple negative breast cancer in the UK each year face the frightening reality of limited treatment options - we urgently need to address this.
"Research has already suggested aspirin could improve outcomes for many cancer patients and we hope that Dr Armstrong's trial will show the same to be true for patients with triple negative breast cancer, so that we can prevent more lives being lost to this devastating disease."
Breast Cancer Now said pharmaceutical company Pfizer had provided funding through an independent medical research grant, while also giving the researchers access to several Pfizer medicines.
Aspirin could be part of a new treatment for an aggressive form of breast cancer, if trials are successful.
Reference: Sky News:
Articles - Most Read
- LIVER DIS-EASE AND GALL BLADDER DIS-EASE
- African Wholistics - Medicines, Machines and Ignorance
- African Holistics - Seduced by Ignorance and Research
- African Wholistics -The Overlooked Revolution
- PART ONE: DIS-EASE TREATMENT AND HEALTH-3
- PART ONE: DIS-EASE TREATMENT AND HEALTH-2
- 'Tortured' and shackled pupils freed from Nigerian Islamic school
- The Children of the Sun-3
- Kidney Stones-African Holistic Health
- PART ONE: DIS-EASE TREATMENT AND HEALTH-5
- PART ONE: DIS-EASE TREATMENT AND HEALTH-4
- The Serpent and the RainBow-The Jaguar - 2
- African Wholistics - Medicine
- King Leopold's Ghost - Introduction
- PART ONE: DIS-EASE TREATMENT AND HEALTH-6
- The Mystery System
- The Black Pharaohs Nubian Pharaohs of Ancient Egypt
- Great Kings and Queens of Africa
- The Children of the Sun - 4
- Enslavement to Emancipation
- Africa - A Brief History - 2
- Medicines Machines and Ignorance-2
Who's On Line?
We have 30 guests and no members online
Articles - Latest
- Tuberculosis deaths rise for first time in over a decade due to impact of Covid pandemic, says WHO
- Woman denied liver transplant because she refuses Covid vaccine
- Everything you need to know about urinary tract infections in old age
- New treatment destroys head and neck cancer tumours in trial
- Vitamin D deficiency: The surprising supplement that could stave off the condition
- Tolerance of cannabis is growing just as scientists show that it can cause insanity
- What is a panic attack? How to spot the signs and be able to tackle it
- E.coli contamination alert over tap water in thousands of homes
- What is PTSD? Symptoms, causes and how you can get help for it
- The Serpent And The Rainbow- The Frontier of Death - 3
- ‘This illness alone is a pandemic’: Sickle cell patients hit by distressing delay in treatment during Covid-19
- SIX out of every 1 million develop heart inflammation after a 2nd dose
- Doctors in Lithuania remove nails and screws from man's stomach
- New Covid-19 pill in Germany exceeds all expectations
- How MDMA and magic mushrooms could be used to treat mental illness
- Reduce paracetamol use, experts tell pregnant women
- A doctor is raising awareness for ovarian cancer symptoms after hers were mistaken for a UTI
- Normal blood testing to resume after NHS supplies bolstered by US stocks
- What's the rarest blood type?
- Oxygen therapy may slow Alzheimer’s, study finds
- The Traders are Kidnapping Our People-4-King Leopold's Ghost
- What are the signs of dyspraxia and do you have it?